All listings for this product
Best-selling in Textbooks
Save on Textbooks
- AU $14.50Trending at AU $17.20
- AU $72.88Trending at AU $77.86
- AU $32.75Trending at AU $55.58
- AU $91.99Trending at AU $100.05
- AU $29.99Trending at AU $32.19
- AU $82.00Trending at AU $96.28
- AU $19.03Trending at AU $22.17
About this product
- DescriptionMaking a commitment in advance to buy vaccines if and when they are developed would create incentives for industry to increase investment in research and development. New commercial investment would complement funding of research and development by public and charitable bodies, accelerating the development of vital new vaccines for the developing world. This report presents the proposal from theory to practice, by showing how a commitment can be consistent with ordinary legal and budgetary principles. By creating arrangements that devote the same scientific effort to diseases of the poor as we put into diseases of the rich, we can make a lasting contribution to the defeat of poverty.
- Author BiographyRuth Levine , senior fellow and Director of Programs at the Center for Global Development, currently leads the Center's Global Health Policy Research Network, USA. Michael Kremer is a professor in the Department of Economics at Harvard University, and senior fellow at the Brookings Institution, USA. Alice Albright is the Chief Executive Officer for the Global Partnership for Education, USA.
- PublisherCentre for Global Development
- Date of Publication29/04/2005
- SubjectIndustrial Studies: General
- Place of PublicationWashington
- Country of PublicationUnited States
- ImprintCentre for Global Development
- Content Notecol. Illustrations
- Weight28 g
- Width178 mm
- Height241 mm
- Spine8 mm
- Edited byAlice Albright,Michael Kremer,Owen Barder,Ruth Levine
- Format DetailsTrade paperback (US)
This item doesn't belong on this page.
Thanks, we'll look into this.